Volume 13, Issue 2 (4-2016)                   Mod Care J 2016, 13(2): 0-0 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Izadpanah A M, Sharifzadeh G, Tabiee S, Parsanasary A, Unesi Z. Determining the Level of Anti-Hepatitis B Surface Antibody in Nursing and Allied Nursing Students in Birjand University of Medical Sciences, 2013. Mod Care J 2016; 13 (2)
URL: http://mcj.bums.ac.ir/article-1-49-en.html
1- East Nursing and Midwifery Research Center, Birjand University of Medical Sciences, Birjand, IR Iran
2- Gholamreza Sharifzadeh, Assistant Professor of Epidemiology, Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, IR Iran. E-mail: rezamood@yahoo.com
3- ر East Nursing and Midwifery Research Center, Birjand University of Medical Sciences, Birjand, IR Iran
Abstract:   (15 Views)
Background: Hepatitis B infection is one of the common diseases worldwide and the most prevalent communicable virus transferred by blood to the healthcare personnel. Active immunity is the most effective measure to prevent hepatitis B infection. The present study aimed at determining hepatitis B surface antibody (HBsAb) in nursing students in Iran, 2013. Methods: The present cross sectional study was conducted on 178 students of nursing, anesthesia, and operating room. They had been fully vaccinated against hepatitis B. HBsAb level was determined in blood samples by enzyme-linked Immunosorbent Assay (ELISA) and Dialab kit made in Italy. Independent t test, ANOVA, and the Tukey range test were used to analyze the data. The level of significance was < 0.05. Results: HBsAb level of 4 (2.2%) cases was below 10 mIU/L, 109 (61.3%) had an HBsAb level between 10 and 100 mIU/L, and in 65 (36.5%) cases, HBsAb level was above 100 mIU/L. Mean HBsAb level in the cases was 95.71 ± 61.4 mIU/L. There was no statistically significant difference among the means of HBsAb in terms of gender, time elapsed from the last vaccination, and time to attend training (P< 0.05). Conclusions: In general, it can be concluded that due to high immunogenicity of hepatitis B vaccine, serological immune response assessment of vaccinated individuals is not necessary except for special and risky groups and, therefore, not recommended
Full-Text [PDF 111 kb]   (17 Downloads)    
Article Types: Research Article | Subject: General
Received: 2026/01/10 | Accepted: 2016/04/15 | Published: 2016/04/15

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Modern Care Journal

Designed & Developed by : Yektaweb